DK1007052T3 - Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelse - Google Patents

Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelse

Info

Publication number
DK1007052T3
DK1007052T3 DK98942166T DK98942166T DK1007052T3 DK 1007052 T3 DK1007052 T3 DK 1007052T3 DK 98942166 T DK98942166 T DK 98942166T DK 98942166 T DK98942166 T DK 98942166T DK 1007052 T3 DK1007052 T3 DK 1007052T3
Authority
DK
Denmark
Prior art keywords
progesterones
oral contraception
endometrically
atrophizing
sparing
Prior art date
Application number
DK98942166T
Other languages
English (en)
Inventor
Michael Kafrissen
Haya Taitel
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1007052T3 publication Critical patent/DK1007052T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK98942166T 1997-08-27 1998-08-20 Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelse DK1007052T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5710997P 1997-08-27 1997-08-27
EP98942166A EP1007052B1 (en) 1997-08-27 1998-08-20 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
PCT/US1998/017288 WO1999009993A1 (en) 1997-08-27 1998-08-20 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception

Publications (1)

Publication Number Publication Date
DK1007052T3 true DK1007052T3 (da) 2005-01-31

Family

ID=22008560

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98942166T DK1007052T3 (da) 1997-08-27 1998-08-20 Kombinationer af endometrisk skånende progesteroner og endometrisk atrofiserende progesteroner med östrogener ved oral svangerskabs-forebyggelse

Country Status (9)

Country Link
EP (1) EP1007052B1 (da)
JP (1) JP2001513566A (da)
AT (1) ATE279198T1 (da)
AU (1) AU9028098A (da)
DE (1) DE69827017T2 (da)
DK (1) DK1007052T3 (da)
ES (1) ES2230711T3 (da)
PT (1) PT1007052E (da)
WO (1) WO1999009993A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US7772219B2 (en) * 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
CA2771944A1 (en) * 2003-07-16 2005-01-27 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
AU2004277998A1 (en) * 2003-10-01 2005-04-14 Janssen Pharmaceutica N.V. Extended triphasic contraceptive regimens
EP1535618A1 (en) 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
FI101601B (fi) * 1987-09-24 1998-07-31 Jencap Res Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
DE4104385C1 (da) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
DE69827017T2 (de) 2006-03-09
AU9028098A (en) 1999-03-16
DE69827017D1 (de) 2004-11-18
EP1007052B1 (en) 2004-10-13
WO1999009993A1 (en) 1999-03-04
PT1007052E (pt) 2005-01-31
ES2230711T3 (es) 2005-05-01
EP1007052A1 (en) 2000-06-14
ATE279198T1 (de) 2004-10-15
JP2001513566A (ja) 2001-09-04

Similar Documents

Publication Publication Date Title
KR970704430A (ko) 전립선 질환, 자궁내막증 및 비만증의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of prostatic diseases endometriosis and obesity)
CY2009015I2 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
FI20115742L (fi) Mometasonifuroaatin käyttö lääkkeen valmistuksessa
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
LU91429I2 (fr) "Furoate de fluticasone et ses solvates(AVAMYS)"
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
FI972642L (fi) Galeeninen yksikkökoostumus käytettäväksi paikallisesti hedelmöityksen ehkäisyyn ja/tai sukupuoliteitse välittyvien sairauksien ja/tai HIV:n vastaiseen taisteluun
AU2002227184A1 (en) Methods for development and use of diagnostic and therapeutic agents
ES2097748T3 (es) Uso de derivados funcionales de la molecula de adhesion intercelular icam-1 en la terapia antivirica.
IL141235A0 (en) Combined use of an alpha-adrenoceptor antagonist and amuscarinic antagonist in the treatment of benign prostatic hyperplasi
NO20004419L (no) Ny anvendelse
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
TR199801511T2 (xx) Farmas�tik bile�im.
NO308581B1 (no) Anvendelse av et antiprogestin og et progestin ved fremstilling av et medikament, implantat samt prevensjonssett inneholdende disse
NO20025157D0 (no) Kreftterapi
NO995657D0 (no) Kombinasjonsterapi for endring av human seksuell respons
AR030140A1 (es) Composiciones derivadas de la 2-piridinamina y metodos relacionados
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
ATE280588T1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
ATE279198T1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
HUP0003244A3 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases and pharmaceutical compositions thereof
AU1518902A (en) Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
PT874839E (pt) Derivados de furano- e tiofeno-carbotioamidas sua preparacao e sua utilizacao como inibidores da replicacao do hiv-1 e de mutantes do hiv-1